BETHESDA The 2007 annual meeting of the American Society for Biochemistry and Molecular Biology (ASBMB) will feature the latest news about cell biology, signaling pathways, and genome dynamics, with 156 presentations in over 50 sessions. The meeting will also include award lectures and sessions on educational and professional development, minority affairs studies, and the interplay between the biomedical sciences and public policy. The meeting will take place at the Washington Convention Center, 801 Mt. Vernon Place, NW, Washington, D.C., from April 28 to May 2.
The ASBMB meeting will be part of a multi-society meeting called Experimental Biology 2007 (EB 2007), which also includes the annual meetings of the American Association of Anatomists, the American Physiological Society, the American Society for Investigative Pathology, the American Society for Nutrition, and the American Society for Pharmacology and Experimental Therapeutics.
Members of the media need to register during the meeting at the EB 2007 Press Room, located in the Convention Center East Registration Level 1.
More information about the meeting, including a list of all sessions, is available at http://www.asbmb.org/asbmb/site.nsf/main/meetings?opendocument
Brief descriptions of highlighted sessions follow. The times indicated below may vary depending on the time taken by preceding presentations.
SUNDAY, APRIL 29
Topic: Treatment for Depression
Session: Science at Undergraduate Institutions
Time/Location: 4:35 p.m.-5:05 p.m., Room 209C
Title: "Tricyclic Antidepressants, but not the Selective Serotonin Reuptake Inhibitor Fluoxetine, Bind to S1S2 Domain of AMPA Receptors"
Summary: LISA NANCY GENTILE, Associate Professor of Chemistry at the
University of Richmond, Va., will discuss how antidepr
'"/>
Contact: Pat Pages
ppages@asbmb.org
301-634-7366
American Society for Biochemistry and Molecular Biology
23-Apr-2007